Clinical trial
A Multicentre, Non-blinded, Randomised Controlled Trial to Assess the Impact of Regular Early SPEcialist Symptom Control Treatment on Quality of Life in Malignant Mesothelioma - "RESPECT-Meso"
NCT03068117 is registered in ClinicalTrials.gov with Portsmouth Hospitals NHS Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicentre, Non-blinded, Randomised Controlled Trial to Assess the Impact of Regular Early SPEcialist Symptom Control Treatment on Quality of Life in Malignant Mesothelioma - "RESPECT-Meso"
- Lead sponsor
- Portsmouth Hospitals NHS Trust
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 3, 2014
- Completion date
- April 10, 2017
- Enrollment
- 319 (actual)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.